Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1654 1658 1676 1691
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18449907 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | Final Rejection | Boston Scientific Scimed, Inc. |
| 18250406 | PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME | Non-Final OA | IDEMITSU KOSAN CO.,LTD. |
| 18004104 | HUMAN RECOMBINANT ACE2-FC MUTANTS THAT DECOUPLE ANTI-SARS-COV-2 ACTIVITY FROM CARDIOVASCULAR EFFECTS | Final Rejection | Northwestern University |
| 18812726 | LONG ACTING GLP-1/GIP DUAL AGONISTS | Non-Final OA | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| 17323683 | CBX8 CHROMDOMAIN INHIBITORS AND THE USES THEREOF | Non-Final OA | Purdue Research Foundation |
| 18352345 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | Non-Final OA | NOVARTIS AG |
| 18604185 | ANNEXIN TO INHIBIT BACTERIA | Non-Final OA | University of Virginia Patent Foundation |
| 18233783 | METHOD FOR TREATING CANCER EXPRESSING SPARC | Final Rejection | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 17782388 | PEPTIDES THAT ENHANCE NMDA RECEPTOR FUNCTION AND USE THEREOF | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | Final Rejection | CAREGEN CO., LTD. |
| 18796898 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | Final Rejection | BicycleTx Limited |
| 18620789 | METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Final Rejection | Stealth BioTherapeutics Inc. |
| 18271663 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | Non-Final OA | Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd. |
| 18248240 | NOVEL PEPTOIDS AND USE THEREOF FOR PREVENTING OR TREATING CHRONIC PAIN | Final Rejection | Université de Montpellier |
| 18016897 | POLYETHYLENE GLYCOL CONJUGATE DRUG SYNERGIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | Non-Final OA | CHONGQING UPGRA BIOTECHNOLOGY CO., LTD. |
| 17617095 | COMPOSITIONS AND METHODS OF USING SAME FOR TISSUE REGENERATION | Non-Final OA | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
| 16971377 | MC4R Agonist Efficacy in Subjects with MC4R Deficiencies and Impaired NFAT Signaling | Final Rejection | Charite - Universitatsmedizin Berlin |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy